I-Orlistat powder

I-CMOAPI ingumkhiqizi omkhulu we-Orlistat we-powder eChina, onamandla we-1800KG izinyanga, futhi ungumnikazi wohlelo oluphelele kakhulu lokuphathwa kwekhwalithi (ISO19001) nohlelo lokuphathwa kwemvelo (14001).

Isigaba: Ukwehlisa isisindo

Incazelo

Imininingwane ye-Orlistat powder Base

Igama	I-Orlistat powder
Ukubukeka	I-powder elimhlophe elimhlophe
CAS	96829-58-2
yokuncwaninga izinsimbi kanye namakhemikhali	≥99%
solubility	I-nsoluble emanzini noma utshwala, i-soluble ku-Acetic acid, i-ethyl ester.
isisindo Yamamolekhula	495.7 g / mol
Melt Point	50 ° C
Formula Yamamolekhula	C9H7ClN2O5
Isikali	30mg
Isitoreji Temp	2-8 ° C Kufriza
Grade	I-Pharmaceutical Grade

Imiphumela Yokulahlekelwa Isisindo Emangazayo Futhi Esheshayo Ku-Orlistat Powder

Kusetshenziswa ubumsulwa 99.7% kwesisindo se-orlistat powder esidalelwe ukuncibilika ngokoqobo amanoni noma ngabe iziguli zenqaba ukuzivocavoca! I-Orlistat Powder evela kumkhiqizi we-CMOAPI idlule ngempumelelo isitifiketi se-GMP ne-DMF, okuyisiqinisekiso sokugcina esingaletha imikhiqizo esezingeni eliphakeme kumakhasimende ethu ngamunye. Futhi ikhwalithi ihumusha ngqo kumakhasimende ajabule, yenyuse ukuthengisa, nesithombe somkhiqizo esithuthukisiwe.

Xhumana Nathi Namuhla

Yini i-Orlistat Powder

I-Orlistat powder isidakamizwa esenzelwe ukusiza iziguli ukulwa nokukhuluphala, into esebenzayo yi-orlistat, ehlanganisa i-Orlistat ne-calorie encishisiwe egadiwe kanye nokudla okunamafutha amancane, ingakhuphula kakhulu ukusebenza kwayo ngenxa yekhono layo lokuvimba ukumuncwa kwamafutha emkhakheni wokugaya ukudla. Ngakho-ke imakethe eminingi yokulahlekelwa kwesisindo engabonakala i-orlistat powder isebenzisa ukunciphisa ukuqoqwa kwama-caloric nokuqoqwa kwamafutha. Njengomuthi kadokotela, i-Orlistat ithengiswa ngaphansi kwegama lomkhiqizo elithi "Xenical", futhi njengesidakamizwa sokulwa nokukhuluphala ngokweqile ngaphansi kwegama lokuhweba "Alli".

Izifundo zasemtholampilo ezenziwa nge-orlistat powder zavumela abacwaningi abathuthukisa ifomula ukuthi bakhiqize ikhompiyutha yokulahleka kwesisindo enamandla kangako ukuthi amafutha amabi ahlanganiswa ngokushesha futhi imiphumela ibonwa emavikini ama-2 kuphela. Ukuhlolwa kwesayensi okuyinkimbinkimbi kwakudingeka ukuthola ukuthi kungani le nto ikhiqiza imiphumela emangalisa kangaka yokwehlisa isisindo.

Kanjani Umsebenzi we-Orlistat Powder & Imiphumela iyamangalisa

I-Orlistat powder iyi-inhibitor ekhethiwe evimba ama-enzyme adiliza amafutha endaweni yokugaya ukudla. Uma sithatha ukudla ngokweqile kwekhalori kuholela ekugcineni ukungafuneki njengamafutha, kuzodala ukuzuza kwesisindo. I-Orlistat powder isebenza ngokunciphisa inani lamafutha umzimba amunca ekudleni. Uma isinanyathiselwe ku-enzyme yesisu kanye ne-pancreatic lipase yakha isibopho esihlanganayo esivimbela ama-enzyme emafutheni e-hydrolyzing adlayo abe ngama-acid nama-monoglycerides.

Ezinye izifundo zibonisa ukuthi umthamo we-Orlistat powder onconyiwe ngu-120 mg, inani lamafutha avinjiwe cishe liyi-30% yamafutha adlayo nsuku zonke. Amafutha angadliwe adlula ohlelweni futhi aqedwe njengodoti. Isebenza ngokuvimbela i-lipases esiswini ne-pancreatic. Lawa ama-enzyme adiliza amafutha adlayo (i-triglycerides) abe yifomu elingathathwa, ama-fatty acid noma i-monoglycerides.

Ungayisebenzisa Kanjani i-Orlistat Powder

Isiguli kufanele simane sithathe i-orlistat powder dose ngamanzi esidlweni ngasinye esikhulu esinamafutha kuze kufike ezikhathini ze-3 ngosuku kuze kufike ehoreni elilodwa ngemuva kokudla. Isidlo ngasinye akufanele sibe nama-calories angaphezu kwama-30% emafutheni.

Njengoba i-orlistat powder inomthelela ekutholeni amavithamini ancibilika njengama-A, D, E, no-K, kunconywa kakhulu ukuthi iziguli zithathe izithasiselo ezifanele zansuku zonke ze-orlistat ukukhokhela noma ikuphi ukusilela okungenzeka. Isikhathi sokudla esinconywayo se-orlistat okungenani amahora angu-2 ngaphambi noma amahora we-2 ngemuva kokuthatha i-orlistat.

Le fomula ye-orlistat powder iyasebenza kakhulu ekukhiqizeni ukulahleka kwesisindo ukuthi iziguli zingaqala ukubona futhi zizwe umzimba ushintsha emasontweni ama-2 kuphela! Ukwelashwa okufanele nge-orlistat Powder kulandela imiyalo elula kungahlehlisa iminyaka yokudla ngokweqile.

Ukuqapha Okubalulekile Ku-Orlistat Powder

IBallance inzuzo yangempela ngemuva kokusebenzisa i-orlistat powder

I-Orlistat powder yenzelwe siza iziguli zishaye ukukhuluphala kanye nesisindo eseqile. Ukusetshenziswa kwayo ngabantu abahlose ukuba nomzimba oyingozi kufanele kugwenywe njengomkhuba ongenampilo futhi oyingozi ngokweqile.
Ngaphandle kokwehla kwesifiso sokudla, iziguli ezelashwa i-Orlistat powder kufanele zilandele ukudla okunempilo ngaphandle kokuzincisha zonke izakhamzimba ezibalulekile.
Ukuhlolwa okuphelele ngaphambi kokwelapha ukuqinisekisa ukuthi isimo sempilo esijwayelekile kuyisibopho.
Imiphumela emibi kakhulu ye-Orlistat powder ikakhulukazi isisu futhi ivela ngenxa yamafutha angadliwe adlula ohlelweni lokugaya ukudla.
Imiphumela emibi ye-Orlistat powder yenzeka phakathi namasonto ambalwa okuqala okuphathwa kwayo futhi ingaphela. Noma kunjalo, ezinye izimpawu zingaqhubeka.
Eminye imiphumela engemihle ingabangelwa isilinganiso se-orlistat powder esingalungile, ngakho-ke ukulandela imiyalo kadokotela kubalulekile.
Kumele kugcizelelwe ngokuqinile ukuthi ukukhuphuka kwamanani we-Orlistat powder akuholeli emiphumeleni enamandla kepha kungaholela ekuphenduleni okungekuhle.

Unemibuzo? Ochwepheshe bethu balapha futhi bayaphendulaUkubuyekezwa kwe-orlistat powder

Xhumana Nathi Namuhla

Ubani Benefits Fi-Orlistat Pisikweletu?

I-Orlistat powder ingumsizi onamandla kunoma yisiphi isimo esidinga ukuqedwa ngokushesha nangokuphumelelayo kwamafutha omzimba amaningi.

1).Ukwelapha ukukhuluphala kuthuthukiswe nge-Orlistat
Njengoba abantu abangama-39% emhlabeni bahlushwa ukuqongelela ngokweqile kwamafutha emzimbeni, ukukhuluphala ngokweqile kungenye yezinkinga ezibucayi kakhulu zezempilo zomphakathi ezaziwa emhlabeni jikelele. Izingozi ezingaba khona ezibandakanya, njengokuphazamiseka kwenhliziyo, isifo sikashukela, umdlavuza othile, nomfutho wegazi ophakeme, kudinga ukuthi kuthathwe izinyathelo ezisheshayo nezanele - okuhleliwe, okugadiwe nokulawulwa kwesisindo.

Okufanelekile, uhlelo lokwehlisa isisindo luqukethe ukudla okwenzelwe wena, ukuzivocavoca umzimba, futhi lapho kunesidingo semithi, futhi kubhekwa njengempumelelo lapho kubangelwa okungenani ukwehla kwesisindo esingu-5% kungakapheli unyaka.

I-Orlistat ngumuthi wokulahlekelwa isisindo onamandla futhi osebenzayo ofakazelwa ukuthi ubamba iqhaza elikhulu ekufezeni umgomo wesisindo. Ucwaningo olubandakanya ababambiqhaza abakhulu ngokweqile be-3,305 luhlolisise umphumela wokuphatha i-120 mg Orlistat kathathu nsuku zonke iminyaka engu-4 kuhlanganiswe nekhalori eliphansi, i-30% -ukudla kwamafutha nokuzivocavoca umzimba okulula kwansuku zonke. Imiphumela ikhombise ukwehla kwesisindo esiphakathi kuka-10.6 kg onyakeni wokuqala. Ukwehla kwesisindo okuthobekile kuqinisekisa ukuthi iziguli zigcina isisindo noma zilahle isisindo esengeziwe ngohlelo oluqhubekayo lokwehlisa isisindo.

2). Ubungozi besifo sikashukela sohlobo lwe-2 bancishisiwe nge-Orlistat
Uhlobo lwesibili sikashukela noma isifo sikashukela yisimo esibi esilimaza umzimba we-glucose emzimbeni. Kuhlotshaniswa nokumelana ne-insulin noma ukukhiqizwa kwe-insulin okunganele ngamanyikwe, ngakho-ke ukungakwazi ukugcina amazinga e-glucose afanele emzimbeni. Ukungazinaki izimpawu zakuqala njengokunyuka ukoma, ukwehla kwesisindo ungahlosile, ukukhathala, ukungaboni kahle, ukutheleleka njalo, kanye namanxeba aphola kancane nokungawabheki kahle kungaholela ezinkingeni ezinkulu ezifana nomfutho wegazi ophezulu, izifo zenhliziyo, nokuhlaselwa yinhliziyo. Ngakho-ke, ukwelashwa okufika ngesikhathi futhi okufanelekile ekugwemeni ukuthuthukiswa kwezinkinga ezengeziwe zezempilo.

Njengesidakamizwa esinamandla sokulahlekelwa isisindo, i-Orlistat powder idlala indima ebaluleke kakhulu ekuvimbeleni ukuqala kohlobo lwesifo sikashukela sohlobo lwe-2. Imiphumela ye-Orlistat ye-powder ingakhulisa ukuzwela kwe-insulin, inciphise ama-fatty acid angakaqinisekisi e-postprandial, yehlise noma ivimbele ukugaywa kwamafutha adlayo, inciphise amafutha we-visceral, futhi yenze uketshezi lwe-glucagon-like peptide-1 emathunjini amancane aphansi.

Ucwaningo lweziguli ezinesifo sokukhuluphala kufakazela ukwehla okukhulu kwezehlakalo zesifo sikashukela sohlobo 2 ngenxa yokwelashwa nge-orlistat okuhambisana nempilo enempilo (ukudla okunamafutha amancane nokuvivinya umzimba). Futhi kwaholela ekulahlekelweni okukhulu kwesisindo. Olunye ucwaningo olwenziwe neziguli ezikhuluphele noma ezikhuluphele ngokweqile ezinesifo sikashukela sohlobo lwe-2 lubandakanya ukuphathwa kwe-120 mg Orlistat kathathu ngosuku izinyanga ze-6 noma ze-12. Ngaphezu komphumela wokwehla kwesisindo, ukuthuthukiswa kokulawulwa kwe-glycemic kwasungulwa, ngokuncipha kokuzila ukudla kwe-plasma glucose (FPG) ne-hemoglobin A1c (HbA1c).

Yonke imininingwane etholwe ngamandla iqinisekisa ukusebenza kahle kokwelashwa nge-orlistat powder, kuhlanganiswe nokudla okuncishiswe kancane-ikhalori, kweziguli ezikhuluphele ngokweqile nezikhuluphele ezitholwe zine-2 yesifo sikashukela.

3). Umfutho wegazi ulawulwa nge-Orlistat
Umfutho wegazi ophakeme owaziwa nangokuthi umfutho wegazi ophakeme yisimo sempilo esibonakala ngomfutho wegazi ongu-systolic ≥ 130 mm Hg noma i-diastolic blood pressure ≥ 80 mm Hg futhi ithinta ngaphezu kuka-30% wabantu abadala emhlabeni jikelele. Kukhonjwa njengobungozi obukhulu bezifo zenhliziyo nemithambo yegazi njengesifo senhliziyo nesifo sohlangothi kepha kuhlotshaniswa nokuhluleka kwenhliziyo, i-arrhythmia, isifo sezinso esingapheliyo kanye nokuwohloka komqondo. Ukukhula komfutho wegazi ophakeme kubangelwa ukukhetha okungenampilo kwempilo njengokuntuleka kokuvivinya umzimba njalo, nezinye izimo zempilo njengesifo sikashukela nokukhuluphala.

Ukuvimbela i-lipase, i-Orlistat ivimbela ukumuncwa kwamafutha adlayo angavimba imithambo futhi kube nomphumela wokwehla komfutho wegazi omncane.

Ucwaningo oluphenya ngemiphumela ye-orlistat olwehlise isisindo somfutho wegazi weziguli ezingama-628 lubike ukwehla okukhulu kwesisindo kanye nokwehla kokubili kwe-diastolic kanye ne-systolic hypertension ngenxa yokunikeza i-120 mg Orlistat kathathu ngosuku unyaka. Ukwehliswa kwe-9.4 mmHg ekucindezelweni kwe-systolic naku-7.7 mmHg ekucindezelweni kwe-diastolic kwarekhodwa. Ngaphezu kwalokho, ukusetshenziswa kwesikhathi eside kwe-orlistat okutholwe kwaholela ekwehliseni kancane umfutho wegazi ngo-2.5 mmHg we-systolic pressure kanye no-1.9 mmHg we-diastolic blood pressure.

Izibalo ezitholwe ezifundweni zikhomba izinzuzo zokusebenzisa i-Orlistat ekwelapheni umfutho wegazi ophakeme wabantu abakhuluphele noma abakhuluphele ngokweqile.

4). Ukunciphisa i-cholesterol ephelele ne-LDL nge-Orlistat
Ingqikithi ye-cholesterol isamba se-low-density lipoprotein (LDL), i-high-density lipoprotein (HDL) cholesterol, kanye ne-20% ye-triglycerides. Ukwakha ezindongeni zemithambo yegazi ukwakha uqwembe, i-cholesterol ye-LDL inesibopho sokunciphisa ingaphakathi lemithambo futhi ivimbele ukuphuma kwegazi. Kwandisa ubungozi kwezempilo futhi kuxhunyaniswa nezimo, njengokuphazamiseka kwenhliziyo nokushaywa unhlangothi.

Ngaphezu kwezinzuzo zokwehlisa isisindo, i-Orlistat kubikwe ukuthi yehlisa i-cholesterol ye-LDL.

Ucwaningo olufaka phakathi iziguli ezingama-294 ezikhuluphele noma ezikhuluphele luhlole imiphumela ye-orlistat esisindweni nase-serum lipids. Ukwelashwa kwamaviki angama-24 kubandakanye umthamo wansuku zonke we-360 mg Orlistat ohlukaniswe kathathu. I-Orlistat itholwe ukuthi yehlisa kakhulu isisindo kanye nengqikithi kanye ne-LDL cholesterol. Kwabuye kwaqinisekiswa ukuthi umphumela wokwehlisa i-cholesterol ye-LDL wawuzimele ezinzuzweni zokwehlisa isisindo. Olunye ucwaningo lwezinyanga eziyi-6 olwaluhlanganisa iziguli ezingama-448 lwaluzinikele ekuboneni imiphumela yokwehlisa i-cholesterol yokwehla kwesisindo kanye nokwelashwa kwe-orlistat. Imiphumela ikhombise ukwehla kwesisindo esiphakathi kuka-7.4 kg. Ngokuhambisana nalokho, ukwehla okuphelele kwe-cholesterol ephelele ne-LDL nge-25-30 mg / dL kwaqoshwa.

I-Orlistat inamandla aqinile osuselwe ebufakazini bokuthuthukisa izimo ezingaxhunyaniswa ngqo noma ngokungaqondile nokukhuluphala nokuqongelela amafutha ngokweqile emzimbeni. Imiphumela ye-Orlistat yandiswa kakhulu lapho ukuphathwa kwayo kuhambisana nokudla okufanele nokuvivinya umzimba ukuze iziguli zizuze ngokugcwele ekwelashweni okwenzelwe izidingo zazo ezithile.

Okuningi Ouhlu Powder Izibuyekezo abaye bahlolwa

Iziguli ezenze i-Orlistat Treatment yazo ziyajabula ukuzibuka esibukweni usuku nosuku bese zibona imiphumela ebonakalayo njengamafutha angafuneki, i-flab, ne-cellulite eqala ukuphela.

- “Ngakho-ke ngo-Okthoba odlule ngaya kudokotela wami ngacela usizo ngoba isisindo sami besingicindezela ngempela. Ngakho-ke wangifaka ku-orlistat futhi manje izinyanga ze-6 ezansi nomugqa ngikhanya nge-16kg, ngisukile kusayizi 18/20 ngaya ku-12/14. Into enhle engake ngayenza. ” - Sez, thatha i-Orlistat Powder izinyanga eziyi-1 kuye kwezi-6.

- “Uqale lokhu ku-Xenical the 13.06.20 at 18st 9lbs and now I'm 16st 0.5lbs and lost 2st 8.5lbs so far, akusebenzi uma ungadli kahle. Kuyakukhuthaza ukuthi udle kahle njengoba usendlini encane ngaso sonke isikhathi uma ungadli kahle, kuze kube manje ulunge kakhulu! Iyishintshile impela impilo yami ”- U-Becks, thatha i-Orlistat Powder izinyanga ezi-1 kuye kwezi-6

- "Ngenkathi ngiqala ukuthatha lo muthi nganginama-235lbs futhi esikhathini esingamasonto ama-4, uswazi lwami luye phansi laya ku-220lbs! 15lbs ngenyanga !! Angizange ngijime ngisho nokuzivocavoca umzimba, ngakho-ke cabanga ukuthi kuningi kangakanani okungenzeka uma ngenza… “- Chris, thatha i-Orlistat Powder izinyanga ezi-1 kuye kwezi-6.

- “Bengilokhu ngiku-orlistat kusukela ngoMeyi 2021 futhi namhlanje (Julayi 2021) ngalinganiswa nokuhlinzwa kwami kwe-drs futhi ngilahlekelwe yitshe le-2 elishaywayo emavikini ayi-7 !! Ngizizwa ngimuhle futhi ngizoqhubeka nokusebenzisa i-orlistat ukungisiza ngilahle isisindo sami. Angikashintshi okuningi ekudleni kwami ngaphandle kokuthi ngiyekile ukudla okulula! ” - isiguli esingaziwa, thatha i-Orlistat Powder izinyanga eziyi-1 kuye kwezi-6.

Kungani To Cukudonsa I-Orlistat Powder From CMOAPI

Thina, kwaCMOAPI, sisebenze amahora amaningi emalebhu futhi sisebenzise imali eningi ukwenza isiqiniseko sokuthi i-Orlistat Powder yethu ihlangabezana nezindinganiso eziphakeme kakhulu zomkhakha futhi iphila ngokuvumelana nokulindelwe kwamakhasimende ngamunye. Izinzuzo ze-orlistat powder yethu yilezi:

7% ukuhlanzeka
Isitifiketi se-GMP ne-DMF
Kuqinisekisiwe ukubonga kwekhwalithi ephezulu eqinisekisiwe kuHlelo Lokulawulwa Kwekhwalithi.

Ziyini izinzuzo zakho ngokusebenzisa i-Orlists Powder yethu?

Ukuhambisana nayo yonke imithetho yomkhakha ehlobene nekhwalithi yento eluhlaza esetshenzisiwe
Ukuletha imikhiqizo yokugcina esezingeni eliphakeme
Ukuqinisekisa imiphumela evelele yeziguli
Kusungulwa isithombe somkhiqizo esihle kakhulu

I-FAQ Ku-Orlistat Powder

Ngabe i-Orlistat powder iyasebenza uma isiguli singadli amafutha?

I-Orlistat powder isebenza ukunciphisa inani lamafutha afakwe emzimbeni. Ngakho-ke ukuthatha i-Orlistat ngesidlo ngaphandle kwamafutha akusebenzi futhi umthamo kufanele weqiwe ukugwema imiphumela emibi ehlobene ne-orlistat.

2.Ingabe i-XENICAL ingathathwa neminye imithi?

Ukusebenzisa lo muthi nganoma iyiphi yale mithi elandelayo akuvamisile ukunconywa, kepha kungadingeka kwezinye izimo:

Abanciphisa igazi, njenge-warfarin, i-heparin, i-apixaban, i-dabigatran ne-rivaroxaban powder
Imithi ye-HIV, efana ne-lopinavir, ritonavir, atazanavir, efavirenz, tenofovir ne-emticitabine.
Imishanguzo yokuquleka
I-Cyclosporine
Amiodarone
Levothyroxine

3.Kude kangakanani ukwelashwa kwe-XENICAL?

I-Orlistat akufanele ithathwe isikhathi esingaphezu kwezinyanga eziyisithupha phezu kwe-counter (ku-60 mg dose Orlistat). Uma isiguli singalahlekanga okungenani i-5% yesisindo sabo ngemuva kokuthatha i-Orlistat izinyanga ezintathu, ukwelashwa kufanele kuqhubeke.

I-4.Ingabe i-Orlistat Powder idala ukulimala kwesibindi?

I-Orlistat powder ayizange ibonwe njengesizathu esiqondile sokulimala okukhulu kwesibindi kuzo zombili izivivinyo zangaphambi komtholampilo kanye nemitholampilo. Kodwa-ke, amanye amacala angavamile okulimala kanzima kwesibindi se-Orlistat powder abikwe ngabantu abawasebenzisile.

I-Orlistat powder inganciphisa ukusebenza kwe-enzyme ebalulekile ebizwa nge-carboxylesterase-2 edlala indima ebalulekile ekuqedeni ubuthi besibindi, izinso, kanye nawo wonke umgudu wamathumbu. Lapho le enzyme ivinjelwe, ubuthi obukhulu bezitho ezibalulekile kungenzeka.

5.Ukuphi ukuthenga i-Orlistat powderonline?

Njengoba abakhiqizi kanye nokuhlushwa kwehluka, imikhiqizo equkethe ukuthengiswa kwe-orlistat inamagama egama le-Orlistat ahlukile. Amanani aphansi we-Orlistat atholakala njengamagama ezimpawu ze-Orlistat anjenge- "Alli" ne- "Orlos" futhi anga-oda kalula online kusuka kubakhiqizi nabaphakeli abaningi be-Orlistat powder.

Ngezinhloso ezengeziwe zobuchwepheshe, ukusebenzisa i-Orlistat Powder ngokuhlanzeka okuphezulu nekhwalithi ehlukile kubaluleke kakhulu. Ngakho-ke, uku-oda impahla eluhlaza okwenziwe ngekhwalithi ephezulu kusuka kubakhiqizi abathembekile kuyazuzisa.

I-CMOAPI ingomunye wabakhiqizi be-Orlistat powder abaqinisekisiwe abanesiko lesikhathi eside embonini futhi baqinisekisa i-orlistat powder esezingeni eliphakeme futhi ehlanganiswe kahle.

Chofoza lapha ukuze Indawo Yyethu Oi-rder

Faka i-oda lakho lapha ukuze uthathe I-CMOAPI ikhwalithi ephezulu engu-99.7% yokulahlekelwa kwesisindo i-Orlistat Powder eyenzelwe ukuncibilikisa amafutha. I-Orlistat Powder yethu iqinisekiswe yi-GMP ne-DMF, okuyisiqinisekiso esikhulu sokuthi siletha imikhiqizo esezingeni eliphakeme kumakhasimende ethu ngamunye.

Xhumana Nathi Namuhla

Okubhekwayo

“Ilebuli ye-orlistat yase-US” (PDF). I-FDA. Agasti 2015. Ibuyiswe ngomhlaka 18 Ephreli 2018. Ukubuyekezwa kwelebula bheka ikhasi lenkomba le-FDA le-NDA 020766
UBarbier P, uSchneider F (1987). "Ama-syntheses we-tetrahydrolipstatin nokulungiswa okuphelele kwe-tetrahydrolipstatin ne-lipstatin". Helvetica Chimica Acta. 70 (1): 196-202. i-doi: 10.1002 / hlca.19870700124.
UBodkin J, uHumphries E, uMcLeod M (2003). “Ukuhlanganiswa okuphelele kwe- (-) - tetrahydrolipstatin”. Ijenali yase-Australia yeKhemistry. 56 (8): 795-803. i-doi: 10.1071 / CH03121.
Filippatos, Theodosios & Derdemezis, Christos & Gazi, Irene & Nakou, Eleni & Mikhailidis, Dimitri & Elisaf, Moses. (2008). Imiphumela Emibi Ehambisana Ne-Orlistat nokusebenzisana kwezidakamizwa Ukuphepha kwezidakamizwa: iphephabhuku lamazwe omhlaba lobuchwepheshe bezokwelapha kanye nesipiliyoni sezidakamizwa 31. 53-65. 10.2165 / 00002018-200831010-00005.
USharma, AM, noGolay, A. (2002). Umphumela wokwehliswa kwesisindo okubangelwa i-orlistat kumfutho wegazi nokushaya kwenhliziyo ezigulini ezikhuluphele ezine-hypertension. Ijenali yomfutho wegazi ophezulu, 20(9), 1873–1878. doi.org/10.1097/00004872-200209000-00034.
Kufakwe isitayela ngosonhlamvukazi omncane ephaketheni, kanye nebha ngaphezulu kwe- i (okungukuthi, “allī”), kepha kufakwa ngofeleba ngokujwayelekile kule ncwajana.
UZhi J, uMelia AT, u-Eggers H, uJoly R, uPatel IH (1995). "Ukubuyekezwa kokumuncwa okulinganiselwe kwe-orlistat, i-lipase inhibitor, kumavolontiya abantu aphilile". UJ Clin Pharmacol. 35 (11): 1103-8. i-doi: 10.1002 / j.1552-4604.1995.tb04034.x. I-PMID 8626884.